InterCure Ltd. (TLV:INCR)
Israel · Delayed Price · Currency is ILS · Price in ILA 244.30
+1.10 (0.45%)
Mar 20, 2026, 1:44 PM IDT
InterCure Market Cap
InterCure has a market cap or net worth of 132.99 million as of March 20, 2026. Its market cap has decreased by -52.98% in one year.
Market Cap
132.99M
Enterprise Value
261.84M
Revenue
243.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
244.30
Market Cap Chart
Since December 16, 2010, InterCure's market cap has increased from 6.41M to 132.99M, an increase of 1,975.06%. That is a compound annual growth rate of 21.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 132.99M | -24.85% |
| Dec 31, 2025 | 176.95M | -34.89% |
| Dec 31, 2024 | 271.76M | 28.77% |
| Dec 31, 2023 | 211.05M | -61.66% |
| Dec 29, 2022 | 550.52M | -40.95% |
| Dec 30, 2021 | 932.28M | 111.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 107.28B |
| Danel (Adir Yeoshua) | 2.62B |
| BrainsWay | 1.70B |
| Kamada | 1.58B |
| Geffen Residence & Renewal | 276.39M |
| Epitomee Medical | 227.43M |
| Golden House | 161.68M |
| Rekah Pharmaceutical Industry | 140.51M |